Location History:
- League City, TX (US) (2016)
- Austin, TX (US) (2021)
- Galveston, TX (US) (2019 - 2024)
Company Filing History:
7 out of 5,450 
5 out of 1,153 
1 out of 528 
Years Active: 2016-2024
Title: Alexander Bukreyev: Innovator in Antibody Research
Introduction
Alexander Bukreyev is a prominent inventor based in Galveston, TX (US). He has made significant contributions to the field of virology, particularly in the development of human antibodies for neutralizing ebolavirus. With a total of 7 patents to his name, Bukreyev's work has the potential to impact public health significantly.
Latest Patents
Among his latest patents is the invention titled "Pan-ebola virus neutralizing human antibodies and methods of use therefor." This patent focuses on human antibodies that bind to and neutralize ebolavirus, along with methods for their application. It includes a monoclonal antibody characterized by clone-paired heavy and light chain CDR sequences. Another notable patent is the "Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease." This invention outlines methods for treating infections caused by ebola and Marburg viruses through the administration of specific compounds.
Career Highlights
Bukreyev has worked with esteemed institutions such as the University of Texas System and Vanderbilt University. His research has been pivotal in advancing our understanding of viral infections and developing therapeutic strategies.
Collaborations
He has collaborated with notable scientists, including James E Crowe, Jr. and Andrew I Flyak. These partnerships have further enriched his research and contributed to the scientific community's knowledge of viral diseases.
Conclusion
Alexander Bukreyev's innovative work in antibody research exemplifies the critical role of inventors in addressing global health challenges. His patents and collaborations continue to pave the way for advancements in the treatment of viral infections.